COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

CENTER FOR BIOMEDICAL RESEARCH TRANSPARENCY INC
NEW YORK, NY · EIN 815180669 · Form 990 · FY2024 · NTEE H11 · Medical Research · Micro (<$100K) · cbmrt.org
revenue
$0
expenses
$4K
net assets
$-44K
employees
0
volunteers
10
program ratio
0%
mission · from form 990

TO ENSURE THAT ALL HIGH QUALITY BIOMEDICAL RESEARCH RESULTS - INCLUDING NEGATIVE AND INCONCLUSIVE RESULTS - ARE ACCESSIBLE TO RESEARCHERS, CLINICIANS AND PATIENTS IN THE INTEREST OF SAFETY AND RESEARCH EFFICIENCY

profile · synthesized from sources

Center for Biomedical Research Transparency (CBMRT) is a nonprofit organization founded in 2017 to improve transparency in biomedical research. It promotes the publication and accessibility of high-quality negative, replicative, and inconclusive research findings to enhance research efficiency and patient care. The organization operates through initiatives like the "Null Hypothesis" publication series and virtual summits, targeting researchers, clinicians, and patients globally.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $0
    PROVIDED VIRTUAL BIOMEDICAL TRANSPARENCY SUMMIT WEBINAR SERIES TO AN AUDIENCE OF OVER 500
named programs · 2 · from sources

What they call their work

Null Hypothesis
A publication initiative in partnership with major medical journals to publish high-quality biomedical studies with negative, replicative, or inconclusive results that are traditionally difficult to publish
Virtual Biomedical Transparency Summit
Webinar series providing a platform for discussion on transparency in biomedical research, reaching an audience of over 500 participants
activities · 3 groups

What they do

  • Open Research Infrastructure & Publishing 3 activities
    • Maintaining a centralized repository for non-positive research
      Manages NullHypothesis.com, a cross-journal online collection that supports the dissemination and discovery of non-positive biomedical research findings.
    • Providing scientific strategy and advisory services
      Provides scientific input and advisory services for organizational initiatives including the Biomedical Transparency Summit, Null Hypothesis, and Transparency Ambassador network, and advises the Board on scientific publication and research conduct.
    • Publishing non-positive biomedical research findings
      Operates Null Hypothesis, a peer-reviewed online journal that publishes negative, replication, and inconclusive biomedical research findings in partnership with Neurology and the American Academy of Neurology, reducing publication bias and improving research direction.
  • Scientific Conference & Symposium Management 1 activity
    • Hosting Biomedical Transparency Summits
      Hosts annual virtual and in-person summit series in the US and EU that convene stakeholders across the research ecosystem to advance transparency in biomedical research, with recent events reaching over 500 attendees.
  • Uncategorized 1 activity
    • Advocating for transparent reporting in biomedical research
      Leads advocacy efforts to promote transparent reporting of biomedical research through collaboration with journals, funders, regulators, and institutions, including advising against patient recruitment in trials when prior evidence indicates likely failure.
financials · form 990 · fy2024
revenue
Total revenue$0
Contributions & grants$0—
Program service revenue$0—
Investment income$0—
Other revenue$0
expenses
Total expenses$4K
Program expenses0%
Admin / overhead100%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineProfessional Fees
balance sheet
Total assets$217K
Cash$217K
Investments$0
Liabilities$261K
Net assets$-44K
Liquid reserves638.0 mo
4 years on record · 2019–2024 · YoY revenue -100.0%
leadership · form 990 part vii · fy2024

Who runs it

board members · 3
  • DR DIMITRIE HUGO STEPHENSON — CEO
  • DR SANDRA PETTY — CHIEF MEDICAL OFFICER
  • ERIC JAFFE — DIRECTOR
relationships · 115

Who they work with

  • ASAPbio Partner — Participated in a CBMRT event, project, or initiative
  • American Academy of Neurology Partner — Collaborated to publish the first edition of the "Null Hypothesis" special journal issue and extended partnership for future publications
  • American Academy of Neurology Partner — Joint initiative partner to promote the publication of negative and inconclusive neurology research.
  • American Academy of Neurology Partner — Participated in a CBMRT event, project, or initiative
  • American Heart Association Partner — Commenced negotiations to publish "Null Hypothesis" content across its 13 journals
  • American Heart Association Partner — Participated in a CBMRT event, project, or initiative
  • Annals of Internal Medicine Partner — Participated in a CBMRT event, project, or initiative
  • Association of Clinical Research Organizations (ACRO) Partner — Participated in a CBMRT event, project, or initiative
  • Atypon Partner — Participated in a CBMRT event, project, or initiative
  • BMC Medicine Partner — Participated in a CBMRT event, project, or initiative
  • Bill & Melinda Gates Foundation Funder — Representatives from the Bill & Melinda Gates Foundation have participated as speakers at BMTS events.
  • Bill & Melinda Gates Foundation Partner — Participated in a CBMRT event, project, or initiative
  • BioCurate Partner — Participated in a CBMRT event, project, or initiative
  • Bioethics International Partner — Participated in a CBMRT event, project, or initiative
  • Boehringer Ingelheim Partner — Participated in a CBMRT event, project, or initiative
  • CISCRP Partner — Participated in a CBMRT event, project, or initiative
  • COPE Partner — Participated in a CBMRT event, project, or initiative
  • Cambridge University Library Partner — Participated in a CBMRT event, project, or initiative
  • Cell Press Partner — Participated in a CBMRT event, project, or initiative
  • Center for Biomedical Research Transparency Network — Organization leading initiatives to improve transparency in biomedical research reporting.
  • Center for Open Science Partner — Participated in a CBMRT event, project, or initiative
  • Center for Open Science Partner — Representatives from the Center for Open Science have spoken at BMTS events.
  • Children's Tumor Foundation Partner — Participated in a CBMRT event, project, or initiative
  • Cochrane Collaboration Partner — Dr. David Tovey, Chair of CBMRT's Scientific Advisory Committee, is Emeritus Editor in Chief of Cochrane, and Dr. Luis-Gabriel Cuervo helped establish the Cochrane Collaboration in Colombia.
  • Cold Spring Harbor Laboratory Press Partner — Participated in a CBMRT event, project, or initiative
  • Columbia University Partner — Participated in a CBMRT event, project, or initiative
  • Cornell University Partner — Participated in a CBMRT event, project, or initiative
  • Council of the Americas Partner — Participated in a CBMRT event, project, or initiative
  • Crohn's & Colitis Foundation Partner — Participated in a CBMRT event, project, or initiative
  • Digital Science & Research Solutions Partner — Participated in a CBMRT event, project, or initiative
+ 85 more
strategies · 5

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Multi-Stakeholder Convening to Advance Systemic Transparency
    methodology: multi_stakeholder_convening
    By convening regulators, funders, publishers, and institutions in cross-sector collaboration, the organization drives adoption of transparency standards because lasting change requires alignment among key actors in the biomedical research ecosystem.
  • Publication of Negative and Inconclusive Results to Correct Bias and Improve Decision-Making
    methodology: publication_bias_correction
    By enabling the publication of negative, inconclusive, and null hypothesis studies, the organization improves the accuracy of scientific understanding and clinical decisions because correcting publication bias reveals the full evidence base for interventions.
  • Three-Pillar Model for Research Transparency
    methodology: three_pillar_model
    By engaging journals, institutions, and funders together, the organization reduces publication bias and increases the dissemination of non-positive research findings because systemic change requires coordinated action across all levels of the research ecosystem.
  • Transparency to Prevent Research Waste and Optimize Investment
    methodology: research_transparency_prevents_waste
    By ensuring all research results are accessible, including negative and inconclusive findings, the organization reduces duplication and failed studies because visibility into prior work allows researchers to build efficiently on existing knowledge.
  • Transparent Reporting as a Foundation for Patient Protection and Better Care
    methodology: transparency_for_patient_protection
    By promoting full disclosure of prior research findings, the organization enables safer trial design and informed decision-making by patients and clinicians because access to complete evidence improves risk assessment and treatment planning.